HOME / Abstract Submission / Call for Abstracts

Abstract Submission Deadline: By Friday, June 14, 2019


Please follow the instructions listed on this website step-by-step:

  • Abstracts submitted via fax will not be accepted.
  • Abstracts must be received by the Abstract Submission Deadline: By Friday, June 14, 2019. Abstracts received after the deadline will not be considered.
  • Submission of an abstract acknowledges your acceptance for the abstract to be published in the official meeting publications.
  • Presenting authors of abstracts must be registered participants. Registration must be received by the Secretariat by the Registration Deadline:
    June 14, 2019 to ensure inclusion of the abstract in the meeting publications and in order to be scheduled for presentation.
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to The International Congress of BMT 2019 (APBMT&ICBMT 2019).
  • Abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. Please note that abstracts submitted with a low level of English will not be considered for presentation
  • Abstract text should be 300 words or less. The word count excludes the abstract title, author names and affiliations.
  • Abstracts stating "data will be discussed in the presentation" will NOT be accepted.

The Scientific Committee will determine whether the abstract will be accepted as an oral presentation, a poster presentation, or a journal publication, with consideration given to the author's preference. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat. APBMT&ICBMT 2019 will publish all accepted abstracts online (open access) for a period of at least 5 years. The abstract published online will include the e-mail address of the presenting author. As a condition of submission, APBMT&ICBMT 2019 requires you to agree to such publication and to surrender any copyright over the abstract as submitted to APBMT&ICBMT 2019.

Abstract Preperation

Before you begin, please prepare the following information:

  • Presenting author's contact details

    - Email address

    - Full postal address

    - Daytime and evening phone number

  • Author and co-authors' details

    - Full first and family name(s).

    - Authors' names must be in upper and lower case (John B Smith).

    - Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Abstract title - Limited to 25 words in UPPER CASE
  • Abstract text - Limited to 300 words, including acknowledgements.

We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.

  • Abstracts must clearly state:
    • • Purpose or Background
    • • Method or Case
    • • Results or Progress
    • • Conclusion or Discussion
  • Abbreviations should be defined on 1st usage, then use of abbreviation alone is OK, i.e. Wilms Tumor (WT), then referred to as "WT" in subsequent mention. Please use as few abbreviations as possible and only commonly used abbreviations
  • Use generic names of drugs. Express numbers as numerals.
  • Abstract category:
    Abstracts must be allocated to a specific category for the scientific program. You will need to select the category most suited to your abstract.

    1. Acute myeloid Leukemia

    - Diagnosis and prognostication
    - Treatment including induction treatment, stem cell transplantation and salvage treatment
    - Clinical trials including novel drugs

    2. Acute lymphoblastic leukemia

    - Diagnosis and prognostication
    - Treatment including induction treatment, stem cell transplantation and salvage treatment
    - Clinical trials including novel drugs

    3. Bone marrow failure including diagnosis and management

    - Aplastic anemia
    - Myelodysplastic syndrome
    - Other disorders

    4. Cellular Therapy

    - In vitro and pre-clinical study
    - Clinical trials with cell therapy

    5. Blood and marrow collection and processing

    - Hematopoietic stem cell collection
    - Mobilization and processing
    - Growth factors and cytokines

    6. Infectious Complications

    - Acute infectious complications related with stem cell transplantation
    - Late infectious complications from transplant survivors
    - Vaccination and prevention of infection

    7. Lymphoma

    - Genomics of lymphoma
    - Induction and salvage treatment for lymphoma
    - Autologous and allogeneic stem cell transplantation for lymphoma
    - Post-transplantation failure management

    8. Post-Transplant Complications (Non-Infective)

    - Acute and chronic GVHD
    - Other acute complications
    - Late complications
    - Long-term survivor management

    9. Myeloma

    - Genomics of myeloma
    - Induction and salvage treatment for myeloma
    - Autologous and allogeneic stem cell transplantation for myeloma
    - Post-transplantation failure management

    10. Nursing/Allied Health

    - Quality of life
    - Stem cell donation
    - Nursing care for stem cell transplantation
    - Nutritional support
    - Education of post-transplant survivors

    11. Pediatrics Hematology/Oncology

    - Pediatric hematologic malignancy
    - Pediatric oncology

    12. Transplantation process and preparative Regimens

    - Conditioning regimens
    - Transplantation protocols
    - Cord blood transplantation
    - Haploidentical transplantation
    - Donor selection process

    13. Stem Cell Biology

    - Cancer stem cells
    - Hematopoietic stem cells

    14. Others

  • No tables or figures should be included.
  • Numbers containing more than 3 digits should have a comma, i.e. 3,000.
  • Disease names should be written without apostrophes, i.e. Hodgkin lymphoma, Non-Hodgkin lymphoma, Burkitt lymphoma, Ewing sarcoma
  • Periods should be used in numbers for decimal points, not commas, i.e., P=0.015
  • Draft abstracts – The submission form at the link below allows you to store your abstract as a draft in order to make changes. Please note that abstracts must be SUBMITTED before the deadline in order to be sent to review for inclusion in the scientific program.